Latest filing published 03 Jan 2014 for Genesis Healthcare, Inc., €11k.
Insider track record
No signal scores available.
Closed purchases
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -52.9%Entry US$7.05 · Close at T+365 US$3.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jose Lynch: trading record in brief
Jose Lynch discloses dealings in Genesis Healthcare, Inc. to SEC (Form 4). In total, 28 filings cover trades dated from 18 May 2007 to 1 January 2014.
Market trades split into 12 purchases (€71k) and 5 sales (€853k). Netting one side against the other leaves €783k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants.
Half of the purchases are above €1,706 and half below. Ninety days after publication, 10 purchases show a median change of +2.8%, with the price up in 100% of them. These figures describe past trades and do not predict future prices.
The newest entry dates from 3 January 2014: a share grant of €11k, in Genesis Healthcare, Inc. The most recent open-market purchase was published on 10 August 2009, 6,300 days ago. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jose Lynch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,284 shares@ US$4.81Class A Common StockSEC:0001398862-14-000003:0
- 7,324 shares@ US$4.81Class A Common StockSEC:0001398862-14-000003:1
- 116,732 shares0Class A Common StockSEC:0001398862-13-000004:0
- 27,322 shares0Class A Common StockSEC:0001398862-13-000002:0
- 416,700 sharesClass A Common StockSEC:0001398862-12-000004:0
- 66,766 shares0Class A Common StockSEC:0001398862-12-000002:0
- 4,400 shares@ US$6.88Class A Common StockSEC:0001398862-12-000002:1
- 2,253 shares@ US$6.90Class A Common StockSEC:0001398862-12-000002:2
- 800 shares@ US$6.91Class A Common StockSEC:0001398862-12-000002:3
- 400 shares@ US$6.92Class A Common StockSEC:0001398862-12-000002:4
- 34,965 shares0Class A Common StockSEC:0001398862-11-000004:0
- 4,837 shares@ US$12.95Class A Common StockSEC:0001398862-11-000002:0
- 50,761 shares0Common StockSEC:0001398862-10-000002:0
- 100 shares@ US$6.90Class A Common StockSEC:0001398862-09-000006:0Canonical exit: 4 Nov 2009 (T+90)
- 300 shares@ US$6.90Class A Common StockSEC:0001398862-09-000006:1Canonical exit: 4 Nov 2009 (T+90)
- 400 shares@ US$6.91Class A Common StockSEC:0001398862-09-000006:2Canonical exit: 4 Nov 2009 (T+90)
- 300 shares@ US$6.93Class A Common StockSEC:0001398862-09-000006:3Canonical exit: 4 Nov 2009 (T+90)
- 100 shares@ US$6.94Class A Common StockSEC:0001398862-09-000006:4Canonical exit: 4 Nov 2009 (T+90)
- 5,000 shares@ US$6.92Class A Common StockSEC:0001398862-09-000006:5Canonical exit: 4 Nov 2009 (T+90)
- 400 shares@ US$6.94Class A Common StockSEC:0001398862-09-000006:6Canonical exit: 4 Nov 2009 (T+90)
- 2,150 shares@ US$6.95Class A Common StockSEC:0001398862-09-000006:7Canonical exit: 4 Nov 2009 (T+90)
- 100 shares@ US$6.91Class A Common StockSEC:0001398862-09-000006:8Canonical exit: 4 Nov 2009 (T+90)
- 500 shares@ US$6.91Class A Common StockSEC:0001398862-09-000006:9Canonical exit: 4 Nov 2009 (T+90)
- 27,322 shares0Class A Common StockSEC:0001398862-08-000002:0
- 70,800 shares0Class A Common StockSEC:0001209191-07-032195:0
25 of 26 declarations